AVL-292

Overview

AVL-292, also known as CC-292, is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, AVL-292 targets and covalently binds to BTK, thereby preventing its activity.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | BTK

Product Information

• Catalog No.: B2693-462475
• CAS No.: 1202757-89-8
• Molecular Formula: C22H22FN5O3
• Molecular Weight: 423.44
• Purity: 98%

Source

Original product source